Negative regulation of PEPCK1 and FASN by TRIM21 reduces sustained gluconeogenesis and inhibits steatosis in hepatocytes, thereby significantly alleviating insulin resistance and glucose intolerance. The gene discussed is FASN; the disease is steatosis.